Compass Financial Management LLC Acquires New Stake in Cigna Group $CI

Compass Financial Management LLC bought a new position in shares of Cigna Group (NYSE:CI) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 4,254 shares of the health services provider’s stock, valued at approximately $1,173,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the fourth quarter worth about $25,000. Cedar Mountain Advisors LLC lifted its position in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares in the last quarter. Johnson Financial Group Inc. purchased a new position in shares of Cigna Group in the second quarter valued at approximately $29,000. Kemnay Advisory Services Inc. purchased a new position in shares of Cigna Group in the fourth quarter valued at approximately $29,000. Finally, Prosperity Bancshares Inc acquired a new position in shares of Cigna Group in the fourth quarter valued at approximately $29,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Down 0.5%

CI stock opened at $276.19 on Monday. The company’s 50 day moving average price is $284.20 and its 200 day moving average price is $281.45. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The firm has a market capitalization of $72.98 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the firm earned $7.20 earnings per share. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities research analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is 25.82%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 23,012 shares of company stock valued at $6,386,550. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on CI. The Goldman Sachs Group upped their target price on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Royal Bank Of Canada boosted their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their price target for the stock from $350.00 to $320.00 in a research note on Monday, August 3rd. Mizuho upped their price objective on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Wolfe Research reiterated an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and a consensus price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.